PharmaTimes6 小时
Libtayo available in Scotland for cervical cancer patients
Regeneron UK Limited has announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo (cemiplimab) for use on ...
PharmaTimes6 小时
Lynparza approved in Scotland for BRCA-mutated breast cancer patients
AstraZeneca announced that its drug Lynparza (olaparib) has been approved for use in Scotland. The approval by the Scottish ...
PharmaTimes1 天
Capgemini unveils AI breakthrough to boost bioeconomy
The methodology, created in the bespoke gen AI-driven biotechnology lab of Cambridge Consultants, part of the Capgemini Group ...
PharmaTimes1 天
Hemgenix shows efficacy among haemophilia B patients
The study shows that 94% of patients eliminated factor IX prophylaxis and maintained near-normal factor IX levels through ...
PharmaTimes5 天
Qureight and Avalyn launch strategic partnership in pulmonary fibrosis
Qureight Ltd and Avalyn Pharma Inc have announced a strategic partnership in progressive pulmonary fibrosis (PPF). The ...
PharmaTimes5 天
FDA grants Orphan Drug Designation to Ariceum cancer therapy
Ariceum Therapeutics, a private biotech company based in Berlin, has announced that the US Food and Drug Administration (FDA) ...
PharmaTimes6 天
Novartis secures MHRA authorisation for ribociclib
Novartis UK announced the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised ribociclib for adjuvant ...
PharmaTimes6 天
Rippon Ubhi
Sanofi has announced that Rippon Ubhi has been appointed as the new Chair of the European Medicines Group (EMG). She will continue her role as Country Lead for Sanofi UK & Ireland alongside this new ...